Global wellness giant Weight Watchers has filed for bankruptcy, while weight-loss drug maker Novo Nordisk cut its full-year forecasts. Read more.

Wegovy's launch in Thaliand comes nearly a month after Eli Lilly launched its obesity management drug Mounjaro in India at ...

Novo Nordisk (NVO) has launched its weight-loss drug Wegovy in Thailand, Reuters reported on Monday, citing an executive of ...

Novo Nordisk has launched its popular weight-loss drug Wegovy in Thailand, marking its first entry into the Southeast Asian ...

Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's ...

Swiss biotech investor Xlife Sciences AG said on Wednesday its portfolio company Veraxa Biotech AG would list on U.S.

He is among four individuals wanted for allegedly using Thai nationals as nominee shareholders to conceal Chinese control of China Railway No 10 (Thailand) Co, a subsidiary of a Chinese state ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind the groundbreaking GLP-1 weight loss drugs Ozempic and Wegovy, have been absolutely plummeting. The company's stock price slid over ...

Five GLP-1RAs are available in the UK-dulaglutide, exenatide, liraglutide, lixisenatide, and semaglutide, which is the active ingredient in Ozempic and Wegovy. Article continues below Ozempic is ...

Blue Cross Blue Shield of Massachusetts says it will soon stop covering popular drugs for weight loss, like Ozempic and Wegovy. The medications have skyrocketed in price and popularity ...

Meanwhile, US-listed shares of the Danish company Novo Nordisk, which markets both Ozempic and the higher-dose weight-loss variant Wegovy, slipped 3.9% amid concerns that a viable oral competitor ...

Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...